Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0124
+0.0003 (2.48%)
Oct 15, 2025, 3:59 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
PHEXXI and SOLOSEC
19.36M
Log In
Log In
Log In
Log In
Upgrade
PHEXXI and SOLOSEC Growth
6.28%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
19.36M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
6.28%
Log In
Log In
Log In
Log In
Upgrade